Watch Out for Exclusive Data Center Reports on Vietnam & Philippines - More than $1 Billion Investment Opportunities in the Next 6 Years tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Atossa Therapeutics (NASDAQ:ATOS – Free Report) in a research report sent to investors on Monday morning, Marketbeat reports. The firm currently has a $4.00 price target on the stock. HC Wainwright also issued estimates for Atossa Therapeutics’ Q4 2023 earnings at ($0.05) EPS, FY2023 earnings at […]
HC Wainwright reiterated their buy rating on shares of Atossa Therapeutics (NASDAQ:ATOS – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The brokerage currently has a $4.00 price objective on the stock. HC Wainwright also issued estimates for Atossa Therapeutics’ Q4 2023 earnings at ($0.05) EPS, FY2023 earnings at […]